JUXTAPID
Identification of Juxtapid
| No description |
Google image searchProduct monograph
Active ingredient
lomitapide (lomitapide mesylate), 5 MG
DIN: 02420341
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: CHIESI FARMACEUTICI S.P.A.
Date: 18-MAR-2024
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AX — Other lipid modifying agents (ATC, ATC/DDD)
- C10AX12 — LOMITAPIDE (ATC/DDD)
Reference brand drug: Juxtapid
